Submitting a REMS (Risk Evaluation and Mitigation Strategies) proposal for risky drug developments could earn companies brownie points, according to Quintiles’ Ed Tabor.
German drug approval and pricing laws are prompting Pharmas to abandon the market says the EFPIA, which has called for ‘urgent action’ to protect innovation and access to medicines.
Outsourcing-Pharma.com presents its weekly round-up of the latest changes within in the world of pharmaceutical careers, including news from AmerisourceBergen, Aviro and Cellectricon.
The upcoming tender for antiretroviral meds (ARVs) in South Africa will be opened up to more companies in a bid to tackle shortages, an insider told us.
The UK pharma manufacturing market is predicted to see a modest 2.7 per cent growth over the next five years largely due to pricing schemes set by the Government, according to a new report.
Negotiating funding for drugs with local health authorities prior to commercialisation is the key to success for biopharmas working in the changing European market, says Quintiles.
in-PharmaTechnologist.com presents its latest weekly line-up of the new faces and places in the pharmaceutical industry, including news from MorphoSys, Pinnacle and Catabasis.
Catalent has upgraded its North Carolina, US, sterile development and analytics plant to increase its aseptic fill-finish activities four-fold in a bid to boost its integrated biologics offering.
Schenck Accurate, Malvern, PSL and Sturtevant have teamed up to create a “unique” new turnkey isolated milling suite which they say will wipe out unnecessary waiting times for high potency (HP) drug processing.
PRA has expanded its operations in the Netherlands and the UK in a bid to meet what it says is soaring client demand for late phase and product registration services.
In-PharmaTechnologist presents its weekly round-up of the latest new appointments in the pharma biz, including news from Pfizer, EMD Millipore and Jubilant.
The US drug industry has welcomed news that Senate has passed the FDA’s amended User Fee Reauthorization Bill in the hopes it will mean a safer global supply chain.
